Team
Our Mission: Let Every Single Cell Tell Its Story
About Us
BioSkryb has ushered in a whole new era of single-cell whole genome amplification. The benefits of the BioSkryb ResolveDNA® technology include the ability to control the amplicon size during amplification. Our complete workflow solution is especially useful in cancer research, as it allows the detection of single resistant mutant cells in heterogeneous cancers such as leukemia. It also enables new applications for gene sequencing that need a level of resolution simply not available today.
Meet our Team
Together, the diverse team at BioSkryb brings a depth of experience in the development of highly sensitive and accurate tools for single-cell analysis, focused on the research and translational needs of new applications that enable improved health management. The company has been rapidly building the infrastructure to make those tools widely available to the research community and others.
BioSkryb’s leadership team has decades of combined scientific and management experience that together sparks the innovations that will change the future of science.
Executive Leadership
Suresh Pisharody
Chief Executive Officer / Board of Directors
Suresh Pisharody is a seasoned executive with a proven track record of building world class businesses and teams in the genomics and molecular diagno…
Charles Gawad, MD, PhD
Chief Scientific Officer / Co-Founder / Scientific Advisory Board / Board of Directors
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Beverly Himes
Chief Financial Officer
Beverly (Bev) Himes is the acting Chief Financial Officer at BioSkryb Genomics. She is also Vice President, Finance and Government Accounting for Anz…
Scientific Advisory Board
William E. Evans, PharmD
Chair of Scientific Advisory Board
Dr. Evans joined St. Jude Children’s Research Hospital (SJCRH) as a student in 1972, joined the faculty in 1976, chaired the Pharmaceutical Sciences …
Mya Thomae
Mya has been working in regulatory, quality and clinical affairs for in vitro diagnostic products since 1990. Mya has worked with FDA and many worldw…
Stefan M. Pfister, MD
Stefan M. Pfister, Prof. Dr. med. Director Preclinical Pediatric Oncology Hopp Children’s Cancer Center Heidelberg (KiTZ) Division Head “Pediatric Ne…
Michael B. Kastan, MD, PhD
He is the William and Jane Shingleton Professor of Pharmacology and Cancer Biology and Professor of Pediatrics at Duke University and serves as the E…
Peter Park, PhD
Dr. Park is a professor of biomedical informatics at Harvard Medical School and the director of its Bioinformatics and Integrative Genomics PhD progr…
Charles Gawad, MD, PhD
Chief Scientific Officer / Co-Founder / Scientific Advisory Board / Board of Directors
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Board of Directors
David Michael
Executive Board Chairman and Managing Partner - Anzu Partners
David Michael is an investor and advisor with nearly 30 years of international business experience. He co-founded Anzu Partners and developed the fir…
William E. Evans, PharmD
Chair of Scientific Advisory Board
Dr. Evans joined St. Jude Children’s Research Hospital (SJCRH) as a student in 1972, chaired the Pharmaceutical Sciences Department from 1986-2002, s…
Suresh Pisharody
Chief Executive Officer / Board of Directors
Suresh Pisharody is a seasoned executive with a proven track record of building world class businesses and teams in the genomics and molecular diagno…
Charles Gawad, MD, PhD
Co-Founder / Scientific Advisory Board / Board of Directors
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Peter Silvester
Board of Directors
Peter Silvester has over 25 years of experience in the life sciences tools industry and most recently served as a Senior Vice President and President…